REPORT DESCRIPTION
Tuberculosis Vaccine Market – Dynamics
Tuberculosis account for the highest amount of death caused due to infectious disease across the globe.
According to the World Health Organization (WHO) factsheet 2018 on TB, 10.4 million people fell ill with
TB in 2016 and 1.7 million people with TB died in the same year. More than 95% of TB deaths occur in
low- and middle-income economies. Deaths caused due to TB also includes death of 0.4 million people
infected with HIV. Such high number of patients across the world confirms the enormity of disease and
urgent requirements for vaccines worldwide. Therefore, the launch of tuberculosis vaccine would gain
significant revenue and in turn, would propel the market growth. According to a global report on
tuberculosis vaccine in 2018, TB costs around US$ 21 billion annually to global economy. Another
important impetus to tuberculosis vaccine market would be current complex drug regime and resistance TB
has created to this drug regime. TB patient has to take more than 2-3 drugs for prolonged time period of 6
months in order to suppress the infection. Often this results in the poor patient compliance and eventually
leads to drug resistance incidence which further deteriorate the TB.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1602